Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98269264 | 9826926 | 4 | F | 201208 | 20150924 | 20140117 | 20151001 | EXP | US-GLAXOSMITHKLINE-A1018109A | GLAXOSMITHKLINE | 0.00 | Y | 0.00000 | 20151001 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98269264 | 9826926 | 1 | PS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Oral | 75 MG AND 50 MG | UNKNOWN | 22291 | 75 | MG | TABLET | QD | |||||
| 98269264 | 9826926 | 2 | SS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Oral | UNK | 22291 | TABLET | |||||||||
| 98269264 | 9826926 | 3 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 4 | C | NOVOLIN N | INSULIN HUMAN | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 5 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 8 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 11 | C | EFFIENT | PRASUGREL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 13 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 14 | C | Hydrocodone | HYDROCODONE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 15 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 16 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 17 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 18 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 19 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 20 | C | Centrum | VITAMINS | 1 | 0 | ||||||||||||
| 98269264 | 9826926 | 21 | C | OCUVITE | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98269264 | 9826926 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98269264 | 9826926 | Adverse event | |
| 98269264 | 9826926 | Drug administration error | |
| 98269264 | 9826926 | Drug ineffective | |
| 98269264 | 9826926 | Headache | |
| 98269264 | 9826926 | Tremor | |
| 98269264 | 9826926 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98269264 | 9826926 | 1 | 201108 | 0 | ||
| 98269264 | 9826926 | 2 | 20120102 | 0 |